– UK, London – LivaNova PLC (LON: LIVN | Nasdaq: LIVN), a market-leading medical technology company, today announced the appointment of Chris Barry to its Board of Directors, effective today.
“The LivaNova Board of Directors is pleased to welcome Chris Barry. Chris has spent his career in the medical technology industry, and we look forward to adding his commercial expertise and ability to drive long-term growth to the Board,” said Board Chair, Bill Kozy.
Chris Barry will also join the Audit and Compliance Committee.
The company also announced that Andrea Saia will retire from the Board on December 31, 2023.
About J. Christopher Barry
With more than two decades of experience in the medical technology industry, Barry most recently served as CEO and Director of NuVasive, Inc., from November 2018 until its merger with Globus Medical, Inc. in September 2023. Prior to that, Barry served as SVP and President of Surgical Innovations for Medtronic plc, from January 2015 to October 2018. Previously, Barry spent 15 years with Covidien plc, in various sales and leadership roles, most recently as President, of Advanced Surgical Technologies, from October 2013 to January 2015. Barry holds a Bachelor of Science degree in Environmental Science from Texas Tech University.
“I am honored to join the LivaNova Board of Directors and look forward to supporting the efforts to bring life-changing improvements to patients around the world while maximizing value to the shareholders,” said Chris Barry.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to providing hope for patients and their families through medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 2,900 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals, and healthcare systems worldwide.
SOURCE: https://www.livanova.com/en-us
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.